S&P 500
5,905.74
-0.6%
-34.72
DJI
42,242.65
-1.0%
-434.59
NASDAQ
$19,091.12
-0.3%
-$51.59
Bitcoin
107,418.00
+2.6%
+2,693.57
AAPL
$205.75
-0.5%
-$1.11
AMZN
$201.43
-1.3%
-$2.64
GOOG
$171.41
+3.7%
+$6.09
META
$640.43
+0.5%
+$3.33
MSFT
$455.56
-0.6%
-$2.61
NVDA
$134.22
-0.1%
-$0.16
TSLA
$342.92
-0.3%
-$0.90
Poseida Therapeutics (NASDAQ: PSTX)
Some price data may be temporarily unavailable.
Poseida Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Poseida Therapeutics Company Info
Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.